Skip to content
  • Kiniksa Pharmaceuticals
Virtual Exhibit Hall
  • 2025 Charleston HFpEF
    • 2025 Charleston HFpEF
    • Abbott
    • Acorai
    • Alleviant Medical
    • Alnylam
    • AstraZeneca
    • Boehringer Ingelheim
    • BridgeBio
    • Bristol Myers Squibb
    • Corvia Medical
    • CVRx
    • Daxor
    • J&J Innovative Medicine
    • Kiniksa Pharmaceuticals
    • Liquidia
    • Merck
    • Novo Nordisk
    • Pfizer Rare Disease
    • Sanofi
    • Takeda
  • 2025 Neonatal Pharmacology
    • 2025 Neonatal Pharmacology
    • Abbott Nutrition
    • Alexion
    • Chiesi USA
    • Childrens Hospital at Erlanger
    • Mothers Milk Bank
    • Prolacta Bioscience
  • 2025 Therapy Update
    • 2025 Therapy Update
    • Exact Sciences
    • Eli Lilly
    • Pfizer
    • Rhythmtx
  • 28th Frontiers in Pediatrics
    • 28th Frontiers in Pediatrics
    • Abbott Nutrition
    • ABS Kids
    • Alexion Pharmaceuticals
    • AstraZeneca
    • CeraVe
    • CSL Seqirus
    • GSK
    • Kate Farms
    • MBERG GROUP
    • Mead Johnson Nutrition
    • Merck
    • MUSC
    • Nutricia
    • ParaPRO LLC
    • Pfizer Vaccines
    • Sanofi Vaccines
    • Sarepta Therapeutics
  • 47th Cardiology Update
    • 47th Cardiology Update
    • Abbott
    • Alnylam
    • Amgen
    • AstraZeneca
    • Boehringer Ingelheim
    • Boston Scientific
    • Bristol Myers Squibb
    • Corvia Medical
    • GE
    • Janssen
    • Kiniksa
    • Lexicon Pharmaceuticals
    • Merck
    • Merck Rare Disease
    • Novo Nordisk
    • Pfizer
    • Pfizer Rare Disease
    • Regeneron
  • Exhibitor Forms

 Silver Level 

Contact:

Jeff Binnicker 
jbinnicker@kiniksa.com / 803.203.0952 

 

Ocean Course

Ocean Course

Kiniksa Pharmaceuticals

Kiniksa logo

 

COMPANY INFORMATION:

Kiniksa is a global biopharmaceutical company that finds and delivers novel treatments for patients with a significant unmet need

PRODUCT:

 https://www.arcalyst.com/

 

www.kiniksa.com